Invista 70 mg Tablet
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Invista 70 mg Tablet

Invista 70 mg Tablet

Invista 70 mg Tablet contains dasatinib 70 mg, a targeted anticancer medicine used for certain blood cancers. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Dasatinib blocks abnormal tyrosine kinase proteins that promote the growth of leukemia cells.

BUY NOW

Category

Invista 70 mg Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib belongs to the tyrosine kinase inhibitor class and inhibits abnormal BCR-ABL and related kinase activity involved in cancer-cell proliferation. The dosage and treatment duration are determined by the treating specialist according to the type and phase of leukemia and the patient’s response to treatment. Regular blood tests and clinical monitoring may be required during therapy.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 70 mg
Dosage Form Tablet
Route Oral
Pack Size 10 Tablets
Manufacturer/Marketer Dr. Reddy’s Laboratories Ltd.

Product Also Known As

Invista 70 mg Tablet, Invista 70 Tablet, Invista Dasatinib Tablet, Dasatinib 70 mg Tablet, Dasatinib Leukemia Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet